Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 109 to 120 of 128 entries
Sorted by: Best Match Show Resources per page
Multiple sclerosis: insights into molecular pathogenesis and therapy.

Mayo Clinic proceedings

Rodriguez M.
PMID: 9212771
Mayo Clin Proc. 1997 Jul;72(7):663-4. doi: 10.1016/s0025-6196(11)63575-1.

No abstract available.

Cite
Rodriguez M. Multiple sclerosis: insights into molecular pathogenesis and therapy. Mayo Clin Proc. 1997;72(7):663-4doi: 10.1016/s0025-6196(11)63575-1.
Rodriguez, M. (1997). Multiple sclerosis: insights into molecular pathogenesis and therapy. Mayo Clinic proceedings, 72(7), 663-4. https://doi.org/10.1016/s0025-6196(11)63575-1
Rodriguez, M. "Multiple sclerosis: insights into molecular pathogenesis and therapy." Mayo Clinic proceedings vol. 72,7 (1997): 663-4. doi: https://doi.org/10.1016/s0025-6196(11)63575-1
Rodriguez M. Multiple sclerosis: insights into molecular pathogenesis and therapy. Mayo Clin Proc. 1997 Jul;72(7):663-4. doi: 10.1016/s0025-6196(11)63575-1. PMID: 9212771.
Copy Download .nbib Format: NLM
Editors' Welcome.

Multiple sclerosis and related disorders

Hawkes C, Lublin F, Giovannoni G, Waubant E.
PMID: 27919509
Mult Scler Relat Disord. 2016 Nov;10:A1. doi: 10.1016/j.msard.2016.11.007.

No abstract available.

Cite
Hawkes C, Lublin F, Giovannoni G, et al. Editors' Welcome. Mult Scler Relat Disord. 2016;10:A1doi: 10.1016/j.msard.2016.11.007.
Hawkes, C., Lublin, F., Giovannoni, G., & Waubant, E. (2016). Editors' Welcome. Multiple sclerosis and related disorders, 10A1. https://doi.org/10.1016/j.msard.2016.11.007
Hawkes, Chris, et al. "Editors' Welcome." Multiple sclerosis and related disorders vol. 10 (2016): A1. doi: https://doi.org/10.1016/j.msard.2016.11.007
Hawkes C, Lublin F, Giovannoni G, Waubant E. Editors' Welcome. Mult Scler Relat Disord. 2016 Nov;10:A1. doi: 10.1016/j.msard.2016.11.007. PMID: 27919509.
Copy Download .nbib Format: NLM
Pediatric multiple sclerosis: Clinical features and outcome.

Neurology

Waldman A, Ness J, Pohl D, Simone IL, Anlar B, Amato MP, Ghezzi A.
PMID: 27572865
Neurology. 2016 Aug 30;87(9):S74-81. doi: 10.1212/WNL.0000000000003028.

Multiple sclerosis (MS) in children manifests with a relapsing-remitting MS (RRMS) disease course. Acute relapses consist of new neurologic deficits persisting greater than 24 hours, in the absence of intercurrent illness, and occur with a higher frequency early in...

Cite
Waldman A, Ness J, Pohl D, et al. Pediatric multiple sclerosis: Clinical features and outcome. Neurology. 2016;87(9):S74-81doi: 10.1212/WNL.0000000000003028.
Waldman, A., Ness, J., Pohl, D., Simone, I. L., Anlar, B., Amato, M. P., & Ghezzi, A. (2016). Pediatric multiple sclerosis: Clinical features and outcome. Neurology, 87(9), S74-81. https://doi.org/10.1212/WNL.0000000000003028
Waldman, Amy, et al. "Pediatric multiple sclerosis: Clinical features and outcome." Neurology vol. 87,9 (2016): S74-81. doi: https://doi.org/10.1212/WNL.0000000000003028
Waldman A, Ness J, Pohl D, Simone IL, Anlar B, Amato MP, Ghezzi A. Pediatric multiple sclerosis: Clinical features and outcome. Neurology. 2016 Aug 30;87(9):S74-81. doi: 10.1212/WNL.0000000000003028. PMID: 27572865.
Copy Download .nbib Format: NLM
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.

Brain : a journal of neurology

Correale J, Gaitán MI, Ysrraelit MC, Fiol MP.
PMID: 27794524
Brain. 2017 Mar 01;140(3):527-546. doi: 10.1093/brain/aww258.

During the past decades, better understanding of relapsing-remitting multiple sclerosis disease mechanisms have led to the development of several disease-modifying therapies, reducing relapse rates and severity, through immune system modulation or suppression. In contrast, current therapeutic options for progressive...

Cite
Correale J, Gaitán MI, Ysrraelit MC, et al. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017;140(3):527-546doi: 10.1093/brain/aww258.
Correale, J., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2017). Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain : a journal of neurology, 140(3), 527-546. https://doi.org/10.1093/brain/aww258
Correale, Jorge, et al. "Progressive multiple sclerosis: from pathogenic mechanisms to treatment." Brain : a journal of neurology vol. 140,3 (2017): 527-546. doi: https://doi.org/10.1093/brain/aww258
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 2017 Mar 01;140(3):527-546. doi: 10.1093/brain/aww258. PMID: 27794524.
Copy Download .nbib Format: NLM
Challenges in Diagnosis and Treatment of Pediatric Multiple Sclerosis.

Acta medica portuguesa

Lopes Silva R.
PMID: 27914150
Acta Med Port. 2016 Aug;29(7):419-420. doi: 10.20344/amp.8054. Epub 2016 Aug 31.

No abstract available.

Cite
Lopes Silva R. Challenges in Diagnosis and Treatment of Pediatric Multiple Sclerosis. Acta Med Port. 2016;29(7):419-420doi: 10.20344/amp.8054.
Lopes Silva, R. (2016). Challenges in Diagnosis and Treatment of Pediatric Multiple Sclerosis. Acta medica portuguesa, 29(7), 419-420. https://doi.org/10.20344/amp.8054
Lopes Silva, Rita. "Challenges in Diagnosis and Treatment of Pediatric Multiple Sclerosis." Acta medica portuguesa vol. 29,7 (2016): 419-420. doi: https://doi.org/10.20344/amp.8054
Lopes Silva R. Challenges in Diagnosis and Treatment of Pediatric Multiple Sclerosis. Acta Med Port. 2016 Aug;29(7):419-420. doi: 10.20344/amp.8054. Epub 2016 Aug 31. PMID: 27914150.
Copy Download .nbib Format: NLM
Advanced Symptom Management in Multiple Sclerosis.

Neurologic clinics

Crabtree-Hartman E.
PMID: 29157400
Neurol Clin. 2018 Feb;36(1):197-218. doi: 10.1016/j.ncl.2017.08.015.

Meaningful symptom management can have a profound impact on quality of life. It can challenge time parameters during clinic, and therefore thought should be given to strategies that can improve efficiency and thereby make the undertaking more tenable. For...

Cite
Crabtree-Hartman E. Advanced Symptom Management in Multiple Sclerosis. Neurol Clin. 2018;36(1):197-218doi: 10.1016/j.ncl.2017.08.015.
Crabtree-Hartman, E. (2018). Advanced Symptom Management in Multiple Sclerosis. Neurologic clinics, 36(1), 197-218. https://doi.org/10.1016/j.ncl.2017.08.015
Crabtree-Hartman, Elizabeth. "Advanced Symptom Management in Multiple Sclerosis." Neurologic clinics vol. 36,1 (2018): 197-218. doi: https://doi.org/10.1016/j.ncl.2017.08.015
Crabtree-Hartman E. Advanced Symptom Management in Multiple Sclerosis. Neurol Clin. 2018 Feb;36(1):197-218. doi: 10.1016/j.ncl.2017.08.015. PMID: 29157400.
Copy Download .nbib Format: NLM
Personalized medicine in multiple sclerosis.

Neurodegenerative disease management

Giovannoni G.
PMID: 29143582
Neurodegener Dis Manag. 2017 Nov;7(6):13-17. doi: 10.2217/nmt-2017-0035.

The therapeutic approach in multiple sclerosis (MS) requires a personalized medicine frame beyond the precision medicine concept, which is not currently implementable due to the lack of robust biomarkers and detailed understanding of MS pathogenesis. Personalized medicine demands a...

Cite
Giovannoni G. Personalized medicine in multiple sclerosis. Neurodegener Dis Manag. 2017;7(6):13-17doi: 10.2217/nmt-2017-0035.
Giovannoni, G. (2017). Personalized medicine in multiple sclerosis. Neurodegenerative disease management, 7(6), 13-17. https://doi.org/10.2217/nmt-2017-0035
Giovannoni, Gavin. "Personalized medicine in multiple sclerosis." Neurodegenerative disease management vol. 7,6 (2017): 13-17. doi: https://doi.org/10.2217/nmt-2017-0035
Giovannoni G. Personalized medicine in multiple sclerosis. Neurodegener Dis Manag. 2017 Nov;7(6):13-17. doi: 10.2217/nmt-2017-0035. PMID: 29143582.
Copy Download .nbib Format: NLM
Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics.

Medicinal chemistry (Shariqah (United Arab Emirates))

Katsara M, Apostolopoulos V.
PMID: 29453907
Med Chem. 2018 Feb 06;14(2):104-105. doi: 10.2174/157340641402180206092504.

No abstract available.

Cite
Katsara M, Apostolopoulos V. Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics. Med Chem. 2018;14(2):104-105doi: 10.2174/157340641402180206092504.
Katsara, M., & Apostolopoulos, V. (2018). Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics. Medicinal chemistry (Shariqah (United Arab Emirates)), 14(2), 104-105. https://doi.org/10.2174/157340641402180206092504
Katsara, Maria, and Apostolopoulos, Vasso. "Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics." Medicinal chemistry (Shariqah (United Arab Emirates)) vol. 14,2 (2018): 104-105. doi: https://doi.org/10.2174/157340641402180206092504
Katsara M, Apostolopoulos V. Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics. Med Chem. 2018 Feb 06;14(2):104-105. doi: 10.2174/157340641402180206092504. PMID: 29453907.
Copy Download .nbib Format: NLM
Muscle strength and power in persons with multiple sclerosis - A systematic review and meta-analysis.

Journal of the neurological sciences

Jørgensen M, Dalgas U, Wens I, Hvid LG.
PMID: 28431618
J Neurol Sci. 2017 May 15;376:225-241. doi: 10.1016/j.jns.2017.03.022. Epub 2017 Mar 18.

BACKGROUND: Multiple sclerosis (MS) is a chronic disease in the central nervous system which causes a number of physical symptoms including impairments of muscle mechanical function (muscle strength, muscle power and explosive muscle strength (~rate of force development, RFD))....

Cite
Jørgensen M, Dalgas U, Wens I, et al. Muscle strength and power in persons with multiple sclerosis - A systematic review and meta-analysis. J Neurol Sci. 2017;376:225-241doi: 10.1016/j.jns.2017.03.022.
Jørgensen, M., Dalgas, U., Wens, I., & Hvid, L. G. (2017). Muscle strength and power in persons with multiple sclerosis - A systematic review and meta-analysis. Journal of the neurological sciences, 376225-241. https://doi.org/10.1016/j.jns.2017.03.022
Jørgensen, Mlk, et al. "Muscle strength and power in persons with multiple sclerosis - A systematic review and meta-analysis." Journal of the neurological sciences vol. 376 (2017): 225-241. doi: https://doi.org/10.1016/j.jns.2017.03.022
Jørgensen M, Dalgas U, Wens I, Hvid LG. Muscle strength and power in persons with multiple sclerosis - A systematic review and meta-analysis. J Neurol Sci. 2017 May 15;376:225-241. doi: 10.1016/j.jns.2017.03.022. Epub 2017 Mar 18. PMID: 28431618.
Copy Download .nbib Format: NLM
Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)

Strupp J, Voltz R, Golla H.
PMID: 26447067
Mult Scler. 2016 Jan;22(1):13-8. doi: 10.1177/1352458515608262. Epub 2015 Oct 07.

Patients severely affected by multiple sclerosis (MS) have a large range of unmet needs. Although initially counterintuitive, specialized palliative care (PC) may be beneficial for these patients and their relatives. PC has advanced greatly in recent years, yet it...

Cite
Strupp J, Voltz R, Golla H. Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis. Mult Scler. 2015;22(1):13-8doi: 10.1177/1352458515608262.
Strupp, J., Voltz, R., & Golla, H. (2016). Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 22(1), 13-8. https://doi.org/10.1177/1352458515608262
Strupp, J, et al. "Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 22,1 (2016): 13-8. doi: https://doi.org/10.1177/1352458515608262
Strupp J, Voltz R, Golla H. Opening locked doors: Integrating a palliative care approach into the management of patients with severe multiple sclerosis. Mult Scler. 2016 Jan;22(1):13-8. doi: 10.1177/1352458515608262. Epub 2015 Oct 07. PMID: 26447067.
Copy Download .nbib Format: NLM
Big data in MS-What can we learn from large international observational studies such as MSBase?.

Multiple sclerosis (Houndmills, Basingstoke, England)

Warnke C, Hartung HP.
PMID: 31397200
Mult Scler. 2020 Jan;26(1):4-5. doi: 10.1177/1352458519868982. Epub 2019 Aug 09.

No abstract available.

Cite
Warnke C, Hartung HP. Big data in MS-What can we learn from large international observational studies such as MSBase?. Mult Scler. 2019;26(1):4-5doi: 10.1177/1352458519868982.
Warnke, C., & Hartung, H. P. (2020). Big data in MS-What can we learn from large international observational studies such as MSBase?. Multiple sclerosis (Houndmills, Basingstoke, England), 26(1), 4-5. https://doi.org/10.1177/1352458519868982
Warnke, Clemens, and Hartung, Hans-Peter. "Big data in MS-What can we learn from large international observational studies such as MSBase?." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 26,1 (2020): 4-5. doi: https://doi.org/10.1177/1352458519868982
Warnke C, Hartung HP. Big data in MS-What can we learn from large international observational studies such as MSBase?. Mult Scler. 2020 Jan;26(1):4-5. doi: 10.1177/1352458519868982. Epub 2019 Aug 09. PMID: 31397200.
Copy Download .nbib Format: NLM
Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era.

Multiple sclerosis and related disorders

Nicholas JA, Shin RK, Alvarez E, Hendin B, Nair KV, Lublin FD.
PMID: 33486401
Mult Scler Relat Disord. 2021 Apr;49:102715. doi: 10.1016/j.msard.2020.102715. Epub 2020 Dec 24.

No abstract available.

Cite
Nicholas JA, Shin RK, Alvarez E, et al. Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era. Mult Scler Relat Disord. 2020;49:102715doi: 10.1016/j.msard.2020.102715.
Nicholas, J. A., Shin, R. K., Alvarez, E., Hendin, B., Nair, K. V., & Lublin, F. D. (2021). Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era. Multiple sclerosis and related disorders, 49102715. https://doi.org/10.1016/j.msard.2020.102715
Nicholas, Jacqueline A, et al. "Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era." Multiple sclerosis and related disorders vol. 49 (2021): 102715. doi: https://doi.org/10.1016/j.msard.2020.102715
Nicholas JA, Shin RK, Alvarez E, Hendin B, Nair KV, Lublin FD. Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era. Mult Scler Relat Disord. 2021 Apr;49:102715. doi: 10.1016/j.msard.2020.102715. Epub 2020 Dec 24. PMID: 33486401; PMCID: PMC7832784.
Copy Download .nbib Format: NLM
Showing 109 to 120 of 128 entries